Skip to content
Back

Rethinking CTR as a Programmatic KPI for Awareness-focused Campaigns

POVRose SumrallJanuary 2, 20253 minute read

Hands on a backlit keyboard under floating dashboards

In the fast-paced world of digital advertising, pharmaceutical marketers are constantly seeking the most effective ways to measure the success of their campaigns. One metric that has long been a staple in the industry is Click-Through Rate (CTR). However, as the digital landscape evolves, it’s becoming clear that CTR may not be the best indicator of success for programmatic awareness-focused campaigns.

The Limitations of CTR

CTR measures the percentage of viewers who click on an advertisement after seeing it. While a high CTR might suggest that an ad is engaging, it doesn’t always provide a complete picture of a campaign’s effectiveness. Here are some of the key challenges pharmaceutical marketers face when relying on CTR:

  1. Upper-Funnel Focus: Programmatic advertising is primarily an upper-funnel channel aimed at enhancing brand visibility and recall. Unlike lower-funnel channels like Paid Search, programmatic ads are designed to reach a broad audience and create awareness rather than driving immediate clicks or conversions. Metrics like reach, impression frequency, and audience quality are more aligned with these objectives.
  2. Quality Over Quantity: CTR only measures the number of clicks, not the quality of those clicks. For pharmaceutical marketers, it’s crucial to understand not just who is clicking, but whether those clicks are coming from qualified, engaged users. Metrics that reflect post-click engagement, such as time spent on the landing page and conversion rates, provide a more comprehensive view of campaign success.
  3. Incentivized and Unintentional Clicks: CTR can be inflated by incentivized or unintentional clicks, leading to misleading performance metrics. This can result in inefficient budget allocation and a distorted view of user engagement. Additionally, click fraud from bots further skews CTR, making it an unreliable metric on its own.
  4. Brand Awareness: CTR focuses on immediate actions rather than long-term brand awareness. Ads that build brand recognition might not get many clicks but can still be valuable in creating lasting impressions and improving brand recall.

Leveraging CTR Effectively

While CTR shouldn’t be the primary metric for awareness campaigns, it can still provide valuable insights when used in conjunction with other KPIs:

  • Creative Performance: Analyzing CTR can help understand the performance of different creative assets during A/B testing. By identifying which creatives generate higher CTRs, marketers can optimize their creative strategy to better resonate with their audience.
  • Post-Click Engagement: Integrating CTR with audience quality metrics and post-click metrics, such as engagement rate and conversion rate, offers a more holistic view of campaign effectiveness. This approach helps determine whether clicks are resulting in meaningful engagement and actions.

A Holistic Approach to KPIs

To truly measure the success of programmatic campaigns, pharmaceutical marketers should prioritize metrics that reflect audience quality and reach. By thoughtfully selecting and analyzing a combination of KPIs, marketers can craft more effective strategies and achieve their marketing objectives. This ensures that every campaign is data-driven and results-oriented, ultimately driving better outcomes for their brands.

If you are curious to learn about how Underscore can help you uplevel your campaign performance, read more about our Media Solutions here.

Sources:

All POVs